Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:


Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Percentage and management strategies for patients undergoing BPH surgery during active surveillance.


  1. Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21:1067–96.

    Article  CAS  PubMed  Google Scholar 

  2. Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62.

    Article  CAS  PubMed  Google Scholar 

  3. Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV. Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US. JAMA Netw Open. 2023;6:e231439.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990–2013. JAMA. 2015;314:80.

    Article  CAS  PubMed  Google Scholar 

  5. Liu Y, Hall IJ, Filson C, Howard DH. Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer. Urol Oncol. 2021;39:432.e1–432.e10.

    Article  PubMed  Google Scholar 

  6. Gravas S, Malde S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, et al. From BPH to male LUTS: a 20-year journey of the EAU guidelines. Prostate Cancer Prostatic Dis. 2023.

  7. Bajpai RR, Razdan S, Sanchez-Gonzalez MA, Reddy BN, Razdan S. Robot-assisted radical prostatectomy after prior transurethral resection of prostate: an analysis of perioperative, functional, pathologic, and oncologic outcomes. J Endourol. 2022;36:1063–9.

    Article  PubMed  Google Scholar 

  8. Kretschmer A, Mazzone E, Barletta F, Leni R, Heidegger I, Tsaur I, et al. Initial experience with radical prostatectomy following holmium laser enucleation of the prostate. Eur Urol Focus. 2021;7:1247–53.

    Article  PubMed  Google Scholar 

  9. Liadi Y, Campbell T, Dike P, Harlemon M, Elliott B, Odero-Marah V. Prostate cancer metastasis and health disparities: a systematic review. Prostate Cancer Prostatic Dis. 2023.

  10. Scheipner L, Incesu RB, Morra S, Baudo A, Assad A, Jannello LMI, et al. Characteristics of incidental prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2023.

  11. Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, et al. Incidental prostate cancer (cT1a–cT1b) Is a relevant clinical and research entity and should be fully discussed in the international prostate cancer guidelines. Eur Urol Oncol. 2022;5:256–8.

    Article  Google Scholar 

  12. Han EA, Nandalur KR, Morgan MA, Arora SS, Loening AM, Bivalacqua TJ, et al. MRI of benign prostatic hyperplasia: important pre- and posttherapeutic considerations. RadioGraphics. 2023;43

Download references

Author information

Authors and Affiliations



Conceptualization and supervision: EB, RA; Data extraction: EB; Data analysis and interpretation: LCL, RSF; Manuscript drafting: EB, AF, FD; Statistical review: AB; Scientific and grammatical review: CL, CD, RA. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Riccardo Autorino.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bologna, E., Licari, L.C., Ditonno, F. et al. Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?. Prostate Cancer Prostatic Dis (2024).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


Quick links